Preliminary report of a multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium study.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 2056-2056 ◽  
Author(s):  
Scott Randall Plotkin ◽  
James H. Tonsgard ◽  
Nicole J. Ullrich ◽  
Jeffrey C. Allen ◽  
Tena L. Rosser ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Preliminary Report ◽  
Vestibular Schwannomas ◽  
Phase 2 ◽  
Neurofibromatosis 2 ◽  
Multicenter Phase ◽  
Phase 2 Study

scholarly journals RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY

2017 ◽  
Vol 19 (suppl_6) ◽  
pp. vi215-vi215
Author(s):  
Scott Plotkin ◽  
James Tonsgard ◽  
Nicole Ullrich ◽  
Jeffrey Allen ◽  
Jashri Blakeley ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Vestibular Schwannomas ◽  
Phase 2 ◽  
Neurofibromatosis 2 ◽  
Multicenter Phase ◽  
Phase 2 Study

Pembrolizumab in mycosis fungoides and Sézary syndrome: Updated results of the CITN multicenter Phase 2 study

2018 ◽  
Vol 101 ◽  
pp. S37 ◽  
Author(s):  
Michael S. Khodadoust ◽  
Alain H. Rook ◽  
Pierluigi Porcu ◽  
Francine Foss ◽  
Alison Moskowitz ◽  
...  
Keyword(s):  
Mycosis Fungoides ◽  
Sézary Syndrome ◽  
Sezary Syndrome ◽  
Phase 2 ◽  
Multicenter Phase ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document